Search form
Search
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
contact us
You are here
Home
»
companies
» DBV Technologies
DBV Technologies
The sector’s most valuable unpartnered assets – up for grabs or on the shelf?
The sector’s most valuable unpartnered assets – up for grabs or on the shelf?
EP Vantage
R&D
Kite Pharma
Incyte
Portola Pharmaceuticals
DBV Technologies
Axovant
AveXis
Flag link:
Europe Biotechs Aim to Catch Americans as Investors Embrace IPOs
Europe Biotechs Aim to Catch Americans as Investors Embrace IPOs
Bloomberg
biotech
IPOs
Europe
DBV Technologies
GW Pharma
Flag link:
DBV files to raise $245M to fuel race for peanut allergy market
DBV files to raise $245M to fuel race for peanut allergy market
Fierce Biotech
DBV Technologies
peanut allergy
Viaskin
Viaskin Peanut
Flag link:
DBV makes a beeline for Phase III as peanut allergy race hots up
DBV makes a beeline for Phase III as peanut allergy race hots up
Fierce Biotech
DBV Technologies
vaccines
food allergies
peanut allergy
Viaskin Peanut
Flag link:
Peanut Allergy Patch Quest Has French Company Spurning Suitors
Peanut Allergy Patch Quest Has French Company Spurning Suitors
Bloomberg
peanut allergy
DBV Technologies
Viaskin
Flag link:
